PPAR-gamma was capable of both reducing cigarette smoke-induced inflammation and protecting against Haemophilus influenzae-induced symptom exacerbations in a mouse model of COPD (Morissette et al. 2015; Solleti et al. 2015). Here, PPARG is linked to chronic obstructive pulmonary disease.